Delos Capital Announces the Launch of Curamir Therapeutics Inc.
HONG KONG, Sept. 20, 2019 /PRNewswire/ — Delos Capital today announces that it has launched Curamir Therapeutics Inc., a Woburn, MA-based biotechnology company pioneering micro RNA (miRNA) based cancer therapeutics, with a $10 million Series A financing. Curamir is incubated through a licensing collaboration with the State University of New York (SUNY) and co-founded by veterans in